Created on November 29, 1993 by the takeover of a plant belonging to Sanofi, the company initially specialized in the production of sterile single-dose polyethylene products such as saline, asthma products and eye drops.
The technology used was Blow Fill Seal (BFS), which made it possible to produce a sterile dose in a single manufacturing step.
The company expanded into global markets, with exports throughout Europe and the development of commercial, operational and regulatory expertise for international customers.
Unither acquired a second plant in Coutances (France) for the manufacture of sterile single-dose units.
In 2005, UNITHER decided to pursue its development by acquiring Créapharm, a French manufacturer specializing in effervescent tablets and benefiting from a development center for third parties.
The launch of Unistick® stick-packs for liquid and paste forms marked a major step forward in our ability to offer single-dose stick solutions.
Unither took over the Colomiers site from Sanofi in order to develop liquid stick-pack technology, thereby expanding the list of products that could be sold in single-dose form.
Launch of Uniflash®, a new patented oral transmucosal drug delivery system (OMC) that is comparable to an intravenous solution.
The company went international with the opening of an office in Brazil.
Unither continued its international expansion by acquiring an American plant from the Belgian group UCB in Rochester.
Unither Pharmaceuticals strengthened its presence on the South American continent through the acquisition of the Brazilian CDMO Mariol Industrial.
Creation of Unither Pharmaceuticals’ subsidiary in China: Unither Pharmaceutical Technologies (Wuhan) Co LTD.
Launch of saline solutions at Gannat plant
First commercial batches of BFS in Rochester
Launch of Preservative-free multidose at Coutances plant
Acquisition of the Unither Nanjing Pharmaceuticals factory in China in Nanjing.
Acquisition of the Novartis plant in Butantã, São Paulo
